Details for New Drug Application (NDA): 017788
✉ Email this page to a colleague
NDA 017788 describes RIMSO-50, which is a drug marketed by Mylan Institutional and is included in one NDA. It is available from one supplier. Additional details are available on the RIMSO-50 profile page.
The generic ingredient in RIMSO-50 is dimethyl sulfoxide. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the dimethyl sulfoxide profile page.
The generic ingredient in RIMSO-50 is dimethyl sulfoxide. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the dimethyl sulfoxide profile page.
Summary for 017788
| Tradename: | RIMSO-50 |
| Applicant: | Mylan Institutional |
| Ingredient: | dimethyl sulfoxide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017788
Suppliers and Packaging for NDA: 017788
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| RIMSO-50 | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 017788 | NDA | Mylan Institutional LLC | 67457-177 | 67457-177-50 | 1 VIAL, GLASS in 1 CARTON (67457-177-50) / 50 mL in 1 VIAL, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVESICAL | Strength | 50% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AT | RLD: | Yes | ||||
Expired US Patents for NDA 017788
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Institutional | RIMSO-50 | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 017788-001 | Approved Prior to Jan 1, 1982 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
